Authors
Shalini Ganeshan1, Mohammad Reza Shakibaie2,3*& Rajaguru Rajagopal4
Abstract
Acinetobacter baumannii(AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 μg/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium.
Documents for download
Stats
- Recommendations +1 100% positive of 1 vote(s)
- Views 387
- Comments 0
